private equity — Lanton Law Blog

FTC, DOJ and HHS Extend RFI on Private Equity Control in Health Care Markets

The Federal Trade Commission, the Department of Justice’s (DOJ) Antitrust Division, and the U.S. Department of Health and Human Services (HHS) are extending the deadline by 30 days for the public to comment on a tri-agency Request for Information (RFI) examining private-equity and other corporations’ increasing control over health care markets. The new deadline is now June 5, 2024.

healthcare, hospitals, IoT, HealthIT, LTC, life sciences, Long term care pharmacy, pharmaceuticals, PhRMA, private equity, SPAC, technologyRon LantonMay 2, 2024private equity firms, private equity, FTC, HHS, DOJ, RFI

The Rise of the Special Purpose Acquisition Company (SPAC)

With the tumultuous chain of events we have witnessed throughout 2020, we have also been hearing more about the rise of SPACs. We have been getting asked more about SPACs such as what they are and what is their role within Wall Street?

banking, finance, fintech, stock market, SEC, SPACRon LantonNovember 20, 2020SPAC, special purpose acquisition company, private equity, Wall Street, hedge funds, IPO, initial public offering, Securities & Exchange Commission, liquidity

Lanton Law & Private Equity

With increasing mergers and acquisitions in both the technology and healthcare sectors, investment opportunities abound for funds and interested stakeholders. In order for these stakeholders to be successful it is essential to know the limits and opportunities within a complex regulatory landscape.

Private Equity Presence Grows in Physician Practices As Well As Congressional Scrutiny

As the consolidation of independent physician practices continues, one finds that there is a new player in the corporatization of medicine. While hospitals, health systems and insurers continue to make physician practice acquisitions, these entities suddenly find themselves competing against private equity firms.

Congress, pharmaceuticals, Medicare, healthcare, physician, Ways and Means Committee, hospitals, insuranceRon LantonFebruary 16, 2020private equity, private equity firms, dermatology, oncology, orthopedics, urology, gastroenterology, physician, reimbursement